Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms

被引:107
作者
Corredor, J
Yan, F
Shen, CC
Tong, W
John, SK
Wilson, G
Whitehead, R
Polk, DB
机构
[1] Vanderbilt Univ, Dept Pediat, Div Gastroenterol & Nutr, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Cell & Dev Biol, Div Gastroenterol & Nutr, Sch Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Med, Div Gastroenterol & Nutr, Sch Med, Nashville, TN 37232 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2003年 / 284卷 / 04期
关键词
intestinal restitution; Src; focal adhesion kinase;
D O I
10.1152/ajpcell.00309.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Altered mucosal integrity and increased cytokine production, including tumor necrosis factor (TNF), are the hallmarks of inflammatory bowel disease (IBD). In this study, we addressed the role of TNF receptors (TNFR) on intestinal epithelial cell migration in an in vitro wound closure model. With mouse TNFR1 or TNFR2 knockout intestinal epithelial cells, gene transfection, and pharmacological inhibitors, we show a concentration-dependent receptor-mediated regulation of intestinal cell migration by TNF. A physiological TNF level (1 ng/ml) enhances migration through TNFR2, whereas a pathological level (100 ng/ml) inhibits wound closure through TNFR1. Increased rate of wound closure by TNFR2 or inhibition by TNFR1 cannot be explained by either increased proliferation or apoptosis, respectively. Furthermore, inhibiting Src tyrosine kinase decreases TNF-induced focal adhesion kinase (FAK) tyrosine phosphorylation and cellular migration. We therefore conclude that TNFR2 activates a novel Src-regulated pathway involving FAK tyrosine phosphorylation that enhances migration of intestinal epithelial cells.
引用
收藏
页码:C953 / C961
页数:9
相关论文
共 59 条
[1]  
Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307
[2]   Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion - Relevance to the pathophysiology of septic shock [J].
Aderka, D ;
Sorkine, P ;
Abu-Abid, S ;
Lev, D ;
Setton, A ;
Cope, AP ;
Wallach, D ;
Klausner, J .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :650-659
[3]   Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease [J].
Arai, F ;
Takahashi, T ;
Furukawa, K ;
Matsushima, K ;
Asakura, H .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (09) :2071-2079
[4]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[5]  
CALALB MB, 1995, MOL CELL BIOL, V15, P954
[6]  
Cary LA, 1996, J CELL SCI, V109, P1787
[7]   Mice carrying an endogenous deletion of the 3′-AU-rich region of the TNFα gene develop a Crohn's disease-like phenotype:: A key role of TNFα in the pathogenesis of chronic intestinal inflammation [J].
Cominelli, F ;
Kontoyiannis, D ;
Pizarro, TT ;
Kollias, G .
GASTROENTEROLOGY, 1998, 114 (04) :A954-A954
[8]  
Corcione A, 1997, BLOOD, V90, P4493
[9]   Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease [J].
Daig, R ;
Andus, T ;
Aschenbrenner, E ;
Falk, W ;
Scholmerich, J ;
Gross, V .
GUT, 1996, 38 (02) :216-222
[10]  
EVERS BM, 1990, ANN SURG, V211, P630